Omron (OTCMKTS:OMRNY - Get Free Report) posted its earnings results on Wednesday. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.05, Zacks reports. The business had revenue of $1.29 billion for the quarter, compared to analysts' expectations of $1.31 billion. Omron had a net margin of 4.04% and a return on equity of 3.49%.
Omron Price Performance
Shares of Omron stock traded up $0.51 during midday trading on Tuesday, hitting $26.22. 38,090 shares of the company were exchanged, compared to its average volume of 54,004. The firm has a 50 day simple moving average of $26.17 and a 200-day simple moving average of $28.29. Omron has a 52 week low of $24.16 and a 52 week high of $47.75. The firm has a market cap of $5.41 billion, a P/E ratio of 23.62 and a beta of 1.03. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.31 and a quick ratio of 1.57.
Omron Company Profile
(
Get Free Report)
OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products.
See Also

Before you consider Omron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.
While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.